Us Congress 2025-2026 Regular Session

House Energy and Commerce Committee Bills & Legislation (Page 9)

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB339

Introduced
1/13/25  
Broadband Resiliency and Flexible Investment Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB407

Introduced
1/20/23  
Refer
1/20/23  
Protect the UNBORN (Undo the Negligent Biden Orders Right Now) Act or the Protect the UNBORN Act This bill prohibits federal implementation of and funding for specified executive orders that address access to reproductive health care services, including services related to pregnancy or the termination of a pregnancy.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB445

Introduced
1/20/23  
Refer
1/20/23  
HHS Reproductive and Sexual Health Ombuds Act of 2023 This bill creates a position within the Department of Health and Human Services to support access to reproductive and sexual health services (including services relating to pregnancy and the termination of a pregnancy) that are evidence-based and medically accurate. Functions of the position include (1) educating the public about medication abortions and other sexual and reproductive health services, (2) collecting and analyzing data about consumer access to and health insurance coverage for those services, and (3) coordinating with the Federal Trade Commission on issues related to consumer protection and data privacy for those services.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB432

Introduced
1/20/23  
Refer
1/20/23  
Buy Low and Sell High Act This bill revises requirements concerning the Strategic Petroleum Reserve (SPR) and sets forth provisions to reduce the demand for petroleum fuel and increase fuel supply. For example, the bill directs the Department of Energy (DOE) to establish within the SPR an Economic Petroleum Reserve of up to 350 million barrels of crude oil. DOE must also establish a national network of Strategic Refined Petroleum Product Reserves to store up to 250 million barrels of gasoline and diesel fuel, which may be sold when there is a severe fuel supply interruption within the district in which the reserve is located. In addition, the bill increases the cap on the amount of barrels of petroleum distillate that may be stored in the Northeast Home Heating Oil Reserve from two million to four million. It also establishes limits on the sale and exportation of petroleum products from such reserves. Further, the bill establishes provisions concerning electrifying the transportation sector, zero-emission vehicles, and a program to increase the amount of crude oil refined in oil refineries in certain countries in the Western Hemisphere.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB379

Introduced
1/14/25  
Healthcare Freedom and Choice ActThis bill nullifies a rule regarding short-term, limited-duration health insurance plans. The rule was promulgated by the Internal Revenue Service, Employee Benefits Security Administration, and Department of Health and Human Services; is titled Short-Term, Limited-Duration Insurance and Independent, Noncoordinated Excepted Benefits Coverage; and was published April 3, 2024.Short-term, limited-duration health insurance plans are plans that may only offer coverage for a limited amount of time and are exempt from the market requirements of the Patient Protection and Affordable Care Act (e.g., coverage of individuals with preexisting conditions).The rule limits the length of the initial contract period for such a plan to no more than three months and, taking into account any renewals or extensions, the maximum coverage period to no more than four months. The rule also includes within the maximum renewal period limitation a new plan sold by the same issuer, or any issuer that is a member of the same controlled group, to the same policyholder within a 12-month period.Regulations in effect prior to the rule this bill nullifies permitted short-term, limited-duration health insurance plans with an initial contract period of fewer than 12 months and a maximum coverage period of up to 36 months, including renewals and extensions.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB382

Introduced
1/14/25  
Exported Carbon Emissions Report Act of 2025This bill directs the Environmental Protection Agency (EPA) to annually collect, calculate, and publish information on certain emissions of carbon dioxide and methane from fossil fuels. Specifically, the EPA must publish information, for each of the previous 10 years, on the total emissions of carbon dioxide and methane that are released (1) within the boundaries of the United States that are the result of the extraction, processing, transportation, combustion, and other use of fossil fuels; and (2) outside the boundaries of the United States that are the result of leakage and combustion of fossil fuels produced or refined in the United States and subsequently exported.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB391

Introduced
1/14/25  
Extend the TikTok Deadline Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB456

Introduced
1/24/23  
Refer
1/24/23  
Fairness in Orphan Drug Exclusivity Act This bill limits which orphan drugs may be granted a market exclusivity period by the Food and Drug Administration (FDA). (Generally, an orphan drug is one that is not economically viable because of the rarity of the disease that it treats; the sponsor of an FDA-designated orphan drug may be granted various incentives, such as a seven-year period in which the FDA may not grant market approval to a different sponsor for the same drug to treat the same disease.) Under this bill, if a drug is designated as an orphan drug on the basis that there is no reasonable expectation that the sponsor will recover the costs of developing and distributing the drug from U.S. sales, the drug shall be granted the seven-year exclusivity period only if the sponsor demonstrates that there is no reasonable expectation that it will recover such costs within its first 12 years of U.S. sales of the drug. When deciding whether an orphan drug meets this requirement, the FDA shall consider the sales of all drugs from the sponsor that are covered by the same orphan drug designation.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB380

Introduced
1/14/25  
Affordable Shipping for All Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB477

Introduced
1/24/23  
Refer
1/24/23  
Community Mentors for Moms Act This bill requires the Health Resources & Services Administration to make grants for demonstration projects that provide community-based maternal mentoring, which may include dedicated individual mentors and networks of peer and community support groups.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB381

Introduced
1/14/25  
LNG Public Interest Determination Act of 2025
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB485

Introduced
1/24/23  
Refer
1/24/23  
Refer
1/24/23  
Report Pass
3/24/23  
Protecting Health Care for All Patients Act of 2023 This bill prohibits all federal health care programs, including the Federal Employees Health Benefits Program, and federally funded state health care programs (e.g., Medicaid) from using prices that are based on quality-adjusted life years (i.e., measures that discount the value of a life based on disability) to determine relevant thresholds for coverage, reimbursements, or incentive programs.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB459

Introduced
1/24/23  
Refer
1/24/23  
Secure Access for Essential Reproductive Health Act of 2023 or the SAFER Health Act of 2023 This bill prohibits health care providers and insurance plans from disclosing in a legal proceeding an individual's personal health information related to an abortion or pregnancy without the individual's valid authorization. The prohibition applies to federal, state, local, and tribal proceedings, including civil, criminal, administrative, and legislative proceedings. The bill provides limited exceptions such as if the information is necessary to investigate physical harm to the individual. Further, the Department of Health and Human Services must conduct an outreach campaign to inform covered entities and the public about the prohibition.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB467

Introduced
1/24/23  
Refer
1/24/23  
Refer
1/24/23  
Report Pass
3/24/23  
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB455

Introduced
1/24/23  
Refer
1/24/23  
Refer
2/3/23  
This bill makes technical corrections in the definitions section of the Controlled Substances Act.